Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial

NCT03559426 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03559426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial
Lead sponsor
University College, London
Phase
Phase 4
Overall status
Completed
Start date
March 24, 2016
Completion date
March 10, 2022
Enrollment
253 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delusional disorder, schizoaffective disorder, schizophrenia, schizophreniform disorders